Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk ...
If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the initiation of treatment for this progressive, relentless diseaseTOKYO and ...
ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food and Drug Administration (FDA) approval for Glatiramer Acetate Injection ...
More than five years after the brutal murders of Edie Yates Henderson and David Henderson in their Lakeland home, Marcelle ...
Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.
Haizol has been recognized as the leading online platform for CNC machining services in China. The ranking evaluated online ...
The lowest doses of the daily pill will cost $149 a month for people paying out of pocket, offering a cheaper alternative to ...
Trump in 2025 announced $12 billion in aid for farmers struggling with tariff impacts. But some worry it may not be enough to ...
24/7 Wall St. on MSN
Here Are Monday’s Top Wall Street Analyst Research Calls: Adobe, Arista Networks, ASML, Coinbase Global, IBM, Marvell Technology, NetFlix, and More
Futures are trading higher as we start the first full week of trading in 2026. Investors and traders who were missing in ...
Halozyme Therapeutics, Inc. and Skye Bioscience, Inc. today announced the companies entered into a non-exclusive global collaboration and license agreement in December 2025. Under the ...
Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Halozyme ...
Road Test: The New Hybrid Porsche 911 Turbo S May Be Polarizing, but It Packs a History-Making Punch
The 2026 model variant is the most powerful production 911 to date, yet still delivers as a standout daily driver.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results